Trials / Active Not Recruiting
Active Not RecruitingNCT04882254
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?
Normothermic Machine Perfusion as Additional Value to Hypothermic Machine Perfusion for Kidney Transplant Outcomes. A Single-centre, Open-label, Randomised, Controlled Trial.
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomised, controlled, phase II trial to assess the efficacy of 2 hours normothermic machine perfusion (NMP) of extended criteria(EC)-DBD (donation after brain death) and DCD (donation after circulatory death) donor kidneys compared to standard care, which is hypothermic machine perfusion (HMP) only in the Netherlands.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Normothermic machine perfusion | Additional 2h of normothermic machine perfusion of the donor kidney with a red cell based perfusate. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2024-05-06
- Completion
- 2025-05-01
- First posted
- 2021-05-11
- Last updated
- 2024-05-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04882254. Inclusion in this directory is not an endorsement.